References of "Gosset, Christiane"
     in
Bookmark and Share    
See detailPilootproject : ontslagmanagement in Belgische ziekenhuizen. [Pilot study : discharge management in Belgian hospitals]. Final report, 2000
Abraham, I; Bollen, S; de Froidmont, C et al

Report (2000)

Detailed reference viewed: 14 (3 ULg)
See detailRapport d’une enquête interne de juin 2000
De Cock, L.; Tellier, V.; Charon, F. et al

Report (2000)

Detailed reference viewed: 2 (0 ULg)
See detailCase Management in Belgium
Gosset, Christiane ULg; de Froidmont, C.

in Case Management in various national elderly assistance systems (1999)

Detailed reference viewed: 16 (0 ULg)
Peer Reviewed
See detailPromising New Agents in Osteoporosis
Reginster, Jean-Yves ULg; Henrotin, Yves ULg; Gosset, Christiane ULg

in Drugs in R&D (1999), 1(3), 195-201

Currently marketed inhibitors of bone resorption or stimulators of bone formation have significantly contributed to a better preventive and therapeutic approach to postmenopausal and senile osteoporosis ... [more ▼]

Currently marketed inhibitors of bone resorption or stimulators of bone formation have significantly contributed to a better preventive and therapeutic approach to postmenopausal and senile osteoporosis. However, none of the available compounds has unequivocally demonstrated an ability to fully prevent the occurrence of new vertebral or peripheral osteoporotic fractures once the disease is established. Therefore, several new medications are being developed, with the aim of providing a better risk-benefit profile and/or a more favourable cost-utility assessment than available drugs. Potential inhibitors of bone resorption include specific inhibitors of the osteoclast's proton pump, inhibitors of prostaglandins or nitric oxide donors. Stimulators of osteoblastic activity and subsequent bone formation might be obtained by strontium salts, peptides of the parathyroid hormone family, growth hormone and insulin-like growth factors or bone morphogenetic proteins. Most of these compounds are now undergoing phase II/III development programmes, and results evaluating their potential benefit should be available within 1 to 5 years. [less ▲]

Detailed reference viewed: 3 (1 ULg)
Full Text
Peer Reviewed
See detailHigh Prevalence of Low Femoral Bone Mineral Density in Elderly Women Living in Nursing Homes or Community-Dwelling: A Plausible Role of Increased Parathyroid Hormone Secretion
Reginster, Jean-Yves ULg; Deroisy, Rita ULg; Pirenne, H. et al

in Osteoporosis International (1999), 9(2), 121-8

The present study was designed to visit elderly women living in nursing homes and to compare their femoral neck bone mineral density (BMD) and circulating levels of parathyroid hormone (PTH) and 25-OH ... [more ▼]

The present study was designed to visit elderly women living in nursing homes and to compare their femoral neck bone mineral density (BMD) and circulating levels of parathyroid hormone (PTH) and 25-OH vitamin D (25-OHD) with those of subjects living at home, in the immediate vicinity of the nursing homes. Of 1483 women, aged 70 years and older, who were selected, 993 agreed to participate in this trial. Their femoral neck BMD (n = 993) was measured by dual-energy X-ray absorptiometry, with a specific device installed in a mobile truck. The circulating levels of 25-OHD and PTH were assessed after an overnight fast (n = 748). After stratification for age, there were no significant differences in mean femoral neck BMD values, prevalence of femoral neck osteoporosis, mean serum 25-OHD and prevalence of absolute or relative 25-OHD deficiency between the two groups. Serum levels of PTH were significantly higher in women over 80 years old living in nursing homes, compared with the community-dwelling women. After adjustment for age, a significant relation was found between femoral neck BMD and PTH levels in the whole population (p = 0.004) and in community-dwelling subjects (p = 0.039). When stratifying our population by quartiles of serum PTH values, the odds ratios for femoral neck osteoporosis were significantly increased for the top two quartiles compared with the lowest one both before (p = 0.00146) and after (p = 0.0013) adjustment for age and type of housing. From this study we conclude that femoral osteoporosis is largely underestimated in European women. Living in a nursing home is not, per se, a risk factor for decreased femoral BMD, and circulating PTH levels are a key determinant of low femoral bone density and osteoporosis. [less ▲]

Detailed reference viewed: 17 (3 ULg)
Peer Reviewed
See detailCommunication strategy increases osteoporosis awareness in postmenopausal women
Tellier, V; De Maeseneer, J; Cartier, P et al

in Journal of Bone and Mineral Research (1999), 14(S1), 385

Detailed reference viewed: 3 (1 ULg)
Full Text
Peer Reviewed
See detailEffects of an intensive communications strategies on postmenopausal osteoporosis awareness in women
Tellier, V; Ben Sedrine, Wafa ULg; Gosset, Christiane ULg et al

in Arthritis and Rheumatism (1999), 42(S1), 356

Detailed reference viewed: 6 (2 ULg)